Market Tracker

07/29 5:16pm ET

Cytokinetics Inc (NASDAQ:CYTK)

11.12
Delayed Data
As of 3:59pm ET
 +1.17 / +11.76%
Today’s Change
5.90
Today|||52-Week Range
13.18
+6.31%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close9.95
Today’s open10.41
Day’s range9.86 - 11.16
Volume837,906
Average volume (3 months)322,933
Market cap$394.2M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-53.61%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book5.74

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...+0.02+0.12%
NUTRNutraceutical Intern...-0.06-0.23%
NATRNatures Sunshine Pro...-0.01-0.08%
RIGLRigel Pharmaceutical...-0.05-2.14%
Data as of 3:59pm ET, 07/29/2016

Financials

Last reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts